Skip to main content
SpringerLink
Log in

Ergebnisse der initialen klinischen Prüfung mit parenteraler Sumatriptanapplikation

  • Chapter
Book cover Migräne

  • 38 Accesses

Zusammenfassung

Im Rahmen der Kapitel 2, 4 und 13 wird auf die Bedeutung des serotoninergen Systems für die Pathogenese der Migräne hingewiesen. Eine ausführliche Darstellung der Physiologie und Pharmakologie dieses Systems findet sich in Kap. 12. Dort werden auch die verschiedenen Rezeptoren und Rezeptorsubtypen des serotoninergen Systems vorgestellt.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 64.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 84.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Baar HA, Brand J, Doenicke A, Melchart D, Lüben V, Tryba M, Sahlender HM (1989) Treatment of acute migraine with subcutaneous GR43175 in West Germany. Cephalalgia 9 [Suppl 9]:83–87

    PubMed  Google Scholar 

  2. Brion N, Bons J, Pias J, Bayliss EM, Advenier C (1989) Inidal clinical experience with the use of subcutaneous GR 43175 in treating acute migraine. Cephalalgia 9 [Suppl 9]:79–82

    PubMed  Google Scholar 

  3. Byer J, Gutterman DL, Plachetka JR, Bhattacharyya H (1989) Dose response study for subcutaneous GR43175 in the treatment of acute migraine. Cephalalgia 9 [Suppl 10]:349–350

    Google Scholar 

  4. Callaghan N (1992) Management of migraine. Ir Med J 85:4–6

    PubMed  CAS  Google Scholar 

  5. Dahlöf C (1992) Headache recurrence after subcutaneous sumatriptan — Letter to the editor. Lancet 339:425–426

    Article  PubMed  Google Scholar 

  6. Diener HC, Peters C, Rudzio M, Noe A, Dichgans J, Haux R, Ehrmann R, Tfeh- Hansen P (1991) Ergotamine, flunarizine and sumatriptan do not change cerebral blood flow velocity in normal subjects and migraneurs. J Neurol 238: 245–250

    PubMed  CAS  Google Scholar 

  7. Doenicke A, Siegel E (1987) Pilotstudie mit einem Serotonin-Agonisten (AH 25086 B). Schmerz 1:29–34

    Article  PubMed  CAS  Google Scholar 

  8. Doenicke A, Brand J, Perrin VL (1988) Possible benefit of GR 43175, a novel 5-HTi-like receptor agonist, for the acute treatment of severe migraine. Lancet 1:1309–1311

    Article  PubMed  CAS  Google Scholar 

  9. Ensink FBM, for the Sumatriptan Intemational Study Group (1991) Subcutaneous Sumatriptan in the acute treatment of migraine. J Neurol 238 [Suppl 1]:S66-S69

    Google Scholar 

  10. Ensink FBM, Hanekop GG, Bautz M, Weyland A, Teichmann AE, Hildebrandt J (1991) GR 43.175 (Sumatriptan) zur Behandlung akuter Migräneattacken — I.: Zwischenanalyse der Ergebnisse einer intemationalen Multicenterstudie mit subkutaner Applikation. Nervenheilkunde 10:202–206

    Google Scholar 

  11. Ferrari MD, Saxena PR (1993) Clinical and experimental effects of sumatriptan in humans. Trends Pharmacol Sci 14:129–133

    Article  PubMed  CAS  Google Scholar 

  12. Ferrari M, Bass EM, Ludlow S, Pilgrim AJ (1989) Subcutaneous GR 43175 in the treatment of acute migraine: an intemational study. Cephalalgia 9 [Suppl 10]: 348

    Google Scholar 

  13. Fowler PA, Thomas M, Lacey LF, Andrew P, Dallas FAA (1989) Early studies with the novel 5-HTi-like agonist GR 43175 in healthy volunteers. Cephalalgia 9 [Suppl 9]: 57–62

    PubMed  Google Scholar 

  14. MacGregor EA (1992) Migraine and its treatment. Pharm J 248:285–288

    Google Scholar 

  15. MacIntyre P, Gemmill J, Hogg K, Bhargava B, Hillis S (1992) The effect of subcutaneous sumatriptan (GR 43175) on central haemodynamics and the coronary circulation. Clin Pharmacol Ther 51:152

    Google Scholar 

  16. Pearce JMS (1991) Sumatriptan in migraine. — May be better than aspirin and metoclopramide. BMJ 303:1491

    Article  PubMed  CAS  Google Scholar 

  17. Peroutka SJ (1990) Sumatriptan in acute migraine: pharmacology and review of world experience. Headache 30 [Suppl 2]:554–560

    Article  PubMed  Google Scholar 

  18. Perrin VL, Färkkilä M, Goasguen J, Doenicke A, Brand J, Tfelt-Hansen P (1989) Overview of initial clinical studies with intravenous and oral GR 43175 in acute migraine. Cephalalgia 9 [Suppl 9]:63–72

    PubMed  Google Scholar 

  19. Tfelt-Hansen P, Brand J, Dano P, Doenicke A, Findley LJ, Iversen HK, Melchart D, Sahlender HM (1989) Early clinical experience with subcutaneous GR 43175 in acute migraine: an overview. Cephalalgia 9 [Suppl 9]:73–77

    PubMed  Google Scholar 

  20. The Finnish Sumatriptan Group and the Cardiovascular Clinical Research Group (1991) A placebo-controlled study of intranasal sumatriptan for the acute treatment of migraine. Eur Neurol 31:332–338

    Article  Google Scholar 

  21. The Subcutaneous Sumatriptan Intemational Study Group (1991) Treatment of migraine attacks with sumatriptan. N Engl J Med 325:316–321

    Article  Google Scholar 

  22. The Sumatriptan Auto-Injector Study Group (1991) Self-treatment of acute migraine with subcutaneous sumatriptan using an auto-injector device. Eur Neurol 31: 323–331

    Article  Google Scholar 

  23. Willett F, Curzen N, Adams J, Armitage M (1992) Coronary vasospasm induced by subcutaneous sumatriptan. BMJ 304:1415

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. Christoph Riemasch-Becker
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Franz Bernhard M. Ensink
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Zentrum Anaesthesiologie, Rettungs- und Intensivmedizin, Universität Göttingen, Robert-Koch-Straße 40, 37075, Göttingen, Deutschland

    Franz Bernhard M. Ensink

  2. Klinik für Neurologie, Universität Kiel, Niemannsweg 147, 24105, Kiel, Deutschland

    Dieter Soyka

Rights and permissions

Reprints and permissions

Copyright information

© 1994 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Riemasch-Becker, C., Ensink, F.B.M. (1994). Ergebnisse der initialen klinischen Prüfung mit parenteraler Sumatriptanapplikation. In: Ensink, F.B.M., Soyka, D. (eds) Migräne. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-93522-0_17

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-93522-0_17

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-93523-7

  • Online ISBN: 978-3-642-93522-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation